Tarsus Pharmaceuticals Inc (TARS)

Capital Lease Obligations

$15.90M

Quarterly · Period ending: · USD

TARS logo

TARS Capital Lease Obligations

Latest reported$15.90M
TARS Quarterly Capital Lease Obligations ($164.00K → $15.90M)
High-resolution chart · PNG

TARS capital lease obligations history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tarsus Pharmaceuticals Inc Capital Lease Obligations — Quarterly (USD)
Period endingCapital Lease Obligations (USD)
15,895,000
16,079,000
10,599,000
10,148,000
317,000
384,000
608,000
631,000
605,000
585,000
398,000
423,000
431,000
703,000
773,000
741,000
905,000
1,234,000
1,891,000
2,327,000
2,138,000
677,000
831,000
815,000
855,000
164,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.